Newly announced results of a pivotal phase 3 trial have demonstrated the effectiveness of a new treatment for gonorrhoea. The medicine, zoliflodacin, is the first new drug developed to treat gonorrhoea in over 30 years. More than half of the 930 patients in the trial were from South Africa. Catherine Tomlinson reports.
A landmark global observational study found that many neonates get life-threatening bloodstream infections, or sepsis, and are dying because the antibiotics used to treat them are not effective. Sepsis affects up to 3 million babies a year globally and the study authors estimate that 214 000 newborns die every year from sepsis that has become antibiotic resistant – mainly in low- to middle-income countries. Adele Baleta reports.
Antibiotics play a vital role in the management of bacterial infections, reducing illness, and preventing many deaths. A 2011 report from the UK estimated that they have increased life expectancy by 20 years. However, the extensive use of antibiotics has resulted in drug resistance that threatens to reverse their life-saving power and if the situation is not reversed, it has been estimated that by 2050 as many as 10 million people will die annually of drug-resistant infections. Tiyese Jeranji looks at how antimicrobial resistance plays out in South Africa and the role of pharmacists in the fight against it.
The number of newborn babies dying from neonatal sepsis is rising as the antibiotics used to treat them are not working effectively, a landmark international study has found. Adele Baleta reports on the findings and their implications for newborns in South Africa.